Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Oct;7(5):655-66.
doi: 10.1007/BF01024881.

Mapping by synthetic peptides of the binding sites for acetylcholine receptor on alpha-bungarotoxin

Affiliations

Mapping by synthetic peptides of the binding sites for acetylcholine receptor on alpha-bungarotoxin

M Z Atassi et al. J Protein Chem. 1988 Oct.

Abstract

A set of seven peptides constituting the various loops and most of the surface areas of alpha-bungarotoxin (BgTX) was synthesized. In appropriate peptides, the cyclical (by a disulfide bond) monomers were prepared. In all cases, the peptides were purified and characterized. The ability of these peptides to bind Torpedo californica acetylcholine receptor (AChR) was studied by radiometric adsorbent titrations. Three regions, represented by peptides 1-16, 26-41, and 45-59, were able to bind 125I-labeled AChR and, conversely, 125I-labeled peptides were bound by AChR. In these regions, residues Ile-1, Val-2, Trp-28, Lys-26 and/or Lys-38, and one or all of the three residues Ala-45, Ala-46, and Thr-47, are essential contact residues in the binding of BgTX to receptor. Other synthetic regions of BgTX showed little or no AChR-binding activity. The specificity of AChR binding to peptides 1-16, 26-41, and 45-59 was confirmed by inhibition with unlabeled BgTX. It is concluded that BgTX has three main AChR-binding regions (loop I with N-terminal extension and loops II and III extended toward the N-terminal by residues 45-47).

PubMed Disclaimer

Similar articles

Cited by

References

    1. FEBS Lett. 1976 Sep 15;68(1):1-4 - PubMed
    1. Pharmacol Ther. 1987;34(3):403-51 - PubMed
    1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
    1. Biochem J. 1980 Jan 1;185(1):285-7 - PubMed
    1. Fed Proc. 1987 Jun;46(8):2538-47 - PubMed

Publication types